Literature DB >> 24982577

Spontaneous complete remission of angioimmunoblastic T-cell lymphoma.

Michael S Humeniuk1, Jackson J Liang1, Matthew Howard1, David J Inwards1.   

Abstract

Angioimmunoblastic T-cell lymphoma (AITL) is a rare hematologic neoplasm that typically presents with B symptoms, anemia, and lymphadenopathy. Its overall prognosis is poor, with a 5-year survival rate of 30%. We present a case of AITL that went into spontaneous remission, an uncommon occurrence.

Entities:  

Year:  2014        PMID: 24982577      PMCID: PMC4059581          DOI: 10.1080/08998280.2014.11929126

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN: 0899-8280


  11 in total

Review 1.  Angioimmunoblastic T-cell lymphoma.

Authors:  Ahmet Dogan; Ayoma D Attygalle; Chara Kyriakou
Journal:  Br J Haematol       Date:  2003-06       Impact factor: 6.998

2.  Expression of CXCL13 by neoplastic cells in angioimmunoblastic T-cell lymphoma (AITL): a new diagnostic marker providing evidence that AITL derives from follicular helper T cells.

Authors:  Jehan Dupuis; Karine Boye; Nadine Martin; Christiane Copie-Bergman; Anne Plonquet; Bettina Fabiani; Anne-Catherine Baglin; Corinne Haioun; Marie-Hélène Delfau-Larue; Philippe Gaulard
Journal:  Am J Surg Pathol       Date:  2006-04       Impact factor: 6.394

Review 3.  In immunocompromised patients, Epstein-Barr virus lymphadenitis can mimic angioimmunoblastic T-cell lymphoma morphologically, immunophenotypically, and genetically: a case report and review of the literature.

Authors:  Mark R Steciuk; Susan Massengill; Peter M Banks
Journal:  Hum Pathol       Date:  2011-07-05       Impact factor: 3.466

4.  Clinicopathologic, immunophenotypic, and immunogenotypic analyses of immunoblastic lymphadenopathy-like T-cell lymphoma.

Authors:  K Tobinai; K Minato; T Ohtsu; K Mukai; Y Kagami; M Miwa; S Watanabe; M Shimoyama
Journal:  Blood       Date:  1988-09       Impact factor: 22.113

Review 5.  Angioimmunoblastic-like T-cell non Hodgkin's lymphoma: outcome after chemotherapy in 33 patients and review of the literature.

Authors:  P Pautier; A Devidas; A Delmer; H Dombret; L Sutton; J M Zini; G Nedelec; T Molina; J P Marolleau; P Brice
Journal:  Leuk Lymphoma       Date:  1999-02

6.  The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells.

Authors:  Laurence de Leval; David S Rickman; Caroline Thielen; Aurélien de Reynies; Yen-Lin Huang; Georges Delsol; Laurence Lamant; Karen Leroy; Josette Brière; Thierry Molina; Françoise Berger; Christian Gisselbrecht; Luc Xerri; Philippe Gaulard
Journal:  Blood       Date:  2007-02-06       Impact factor: 22.113

7.  Angioimmunoblastic T cell lymphoma: treatment experience with cyclosporine.

Authors:  Ranjana Advani; Steven Horwitz; Andrew Zelenetz; Sandra J Horning
Journal:  Leuk Lymphoma       Date:  2007-03

8.  Angioimmunoblastic lymphadenopathy. Long-term follow-up study.

Authors:  G A Pangalis; E M Moran; B N Nathwani; R J Zelman; H Kim; H Rappaport
Journal:  Cancer       Date:  1983-07-15       Impact factor: 6.860

Review 9.  Angioimmunoblastic T cell lymphoma: pathobiological insights and clinical implications.

Authors:  Kieron Dunleavy; Wyndham H Wilson; Elaine S Jaffe
Journal:  Curr Opin Hematol       Date:  2007-07       Impact factor: 3.284

10.  Significance of cytogenetic findings for the clinical outcome in patients with T-cell lymphoma of angioimmunoblastic lymphadenopathy type.

Authors:  B Schlegelberger; T Zwingers; K Hohenadel; D Henne-Bruns; N Schmitz; T Haferlach; C Tirier; H Bartels; R Sonnen; R Kuse
Journal:  J Clin Oncol       Date:  1996-02       Impact factor: 44.544

View more
  2 in total

1.  The Incremental Prognostic Value of Baseline 18F-FDG PET/CT Imaging in Angioimmunoblastic T-Cell Lymphoma.

Authors:  Hui Wang; Wenjing Yu; Tao Wu; Yangyang Xue; Dan Zhang; Huiqin Xu
Journal:  Biomed Res Int       Date:  2020-06-06       Impact factor: 3.411

2.  Angioimmunoblastic T-Cell Lymphoma Presenting with an Acute Serologic Epstein-Barr Virus Profile.

Authors:  Timothy Beer; Patrick Dorion
Journal:  Hematol Rep       Date:  2015-06-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.